Merck Forward-Looking StatementThis news release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Merck’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
|1 Alzheimer’s Disease International. Types of Dementia: Alzheimer’s Disease. Available at: http://www.alz.co.uk/info/alzheimers-disease. 2 Alzheimer’s Disease International. Dementia Statistics. Available at: http://www.alz.co.uk/research/statistics. 3 Alzheimer’s Association. Alzheimer’s Fact and Figures. Available at: http://www.alz.org/alzheimers_disease_facts_and_figures.asp.|